← All indications
Haemophilus influenzae type b
A type of H. influenzae isolated most frequently from biotype I. Prior to vaccine availability, it was a leading cause of childhood meningitis.
Drugs by status
Phase 4 trials (7)
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- menitorix
- hepatitis b vaccine (recombinant)
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- Inactivated polio virus - Enhanced
Phase 3 trials (26)
- diphtheria-tetanus-whole cell pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine
- haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine
- meningococcal (groups A, C, Y, W) CRM197 conjugate vaccine
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- tritanrix-hepb
- hepatitis a vaccine, inactivated
- acellular pertussis vaccine
- Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
- glyco-conjugate neisseria meningitidis serogroup c vaccine
- live attenuated varicella vaccine
- pneumococcal 7-valent conjugate vaccine
- 10-valent Pneumococcal Conjugate Vaccine
- polyribosil-ribitol-phosphate vaccine
- measles, mumps, and rubella vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- hib-menac
- bivalent oral polio vaccine (bopv), type 1 and type 3
- diphtheria toxoid
- monovalent group c meningococcal vaccine
- polio, inactivated poliovirus vaccine
- tetanus toxoid
- human rotavirus, live attenuated
- HibMenCY
- Monovalent group C meningococcal vaccine
- Bivalent group A and C meningococcal vaccine